ReviewTranslational lung cancer research2013
ALK and ROS1 as a joint target for the treatment of lung cancer: a review.
Raimon Puig de la Bellacasa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it